Kingswood Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.05M Buy
31,533
+360
+1% +$42.1K 0.16% 146
2026
Q1
$3.75M Sell
31,173
-790
-2% -$91.2K 0.18% 131
2025
Q4
$3.36M Buy
31,963
+3,066
+11% +$288K 0.16% 143
2025
Q3
$2.43M Buy
28,897
+5,262
+22% +$433K 0.15% 156
2025
Q2
$1.87M Sell
23,635
-3,551
-13% -$282K 0.15% 152
2025
Q1
$2.44M Sell
27,186
-3,202
-11% -$299K 0.22% 108
2024
Q4
$3.02M Sell
30,388
-30,518
-50% -$3.15M 0.23% 101
2024
Q3
$6.92M Buy
60,906
+11,004
+22% +$1.31M 0.49% 34
2024
Q2
$6.18M Buy
49,902
+12,188
+32% +$1.57M 0.56% 27
2024
Q1
$4.98M Sell
37,714
-11,715
-24% -$1.44M 0.57% 23
2023
Q4
$5.39M Buy
49,429
+28,263
+134% +$2.93M 0.61% 27
2023
Q3
$4.36M Sell
21,166
-5,364
-20% -$578K 0.74% 25
2023
Q2
$3.06M Buy
+26,530
New +$3.01M 0.98% 21

Other funds holding MRK

Kingswood Wealth Advisors's MRK Position: Q2 2026 in Review

Kingswood Wealth Advisors increased its Merck (MRK) stake by 1.2% in Q2 2026, buying an estimated $42.1K and bringing the position to 31,533 shares worth $4.05M. The position accounts for 0.16% of the portfolio, ranked #146.

Kingswood Wealth Advisors first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.92M in Q3 2024. 2,371 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kingswood Wealth Advisors held 31,533 shares of Merck worth $4.05M as of Q2 2026.
  • Kingswood Wealth Advisors bought 360 Merck shares in Q2 2026, an estimated $42.1K.
  • Merck made up 0.16% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #146 holding.
  • Kingswood Wealth Advisors first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • Kingswood Wealth Advisors's Merck position peaked at $6.92M in Q3 2024.
  • 2,371 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.